US Patent 9580442 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Patent 9580442 was granted and assigned to Karus Therapeutics on February, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9580442 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
